These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 35328504)

  • 41. Aberrant Expression of a Non-muscle RBFOX2 Isoform Triggers Cardiac Conduction Defects in Myotonic Dystrophy.
    Misra C; Bangru S; Lin F; Lam K; Koenig SN; Lubbers ER; Hedhli J; Murphy NP; Parker DJ; Dobrucki LW; Cooper TA; Tajkhorshid E; Mohler PJ; Kalsotra A
    Dev Cell; 2020 Mar; 52(6):748-763.e6. PubMed ID: 32109384
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fuchs' Endothelial Corneal Dystrophy in Patients With Myotonic Dystrophy, Type 1.
    Winkler NS; Milone M; Martinez-Thompson JM; Raja H; Aleff RA; Patel SV; Fautsch MP; Wieben ED; Baratz KH
    Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3053-3057. PubMed ID: 30025114
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sense and Antisense DMPK RNA Foci Accumulate in DM1 Tissues during Development.
    Michel L; Huguet-Lachon A; Gourdon G
    PLoS One; 2015; 10(9):e0137620. PubMed ID: 26339785
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aberrantly spliced alpha-dystrobrevin alters alpha-syntrophin binding in myotonic dystrophy type 1.
    Nakamori M; Kimura T; Kubota T; Matsumura T; Sumi H; Fujimura H; Takahashi MP; Sakoda S
    Neurology; 2008 Feb; 70(9):677-85. PubMed ID: 18299519
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correction of RNA-Binding Protein CUGBP1 and GSK3β Signaling as Therapeutic Approach for Congenital and Adult Myotonic Dystrophy Type 1.
    Timchenko L
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31877772
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Myotonic Dystrophies: A Genetic Overview.
    Soltanzadeh P
    Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205411
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gene expression analysis in myotonic dystrophy: indications for a common molecular pathogenic pathway in DM1 and DM2.
    Botta A; Vallo L; Rinaldi F; Bonifazi E; Amati F; Biancolella M; Gambardella S; Mancinelli E; Angelini C; Meola G; Novelli G
    Gene Expr; 2007; 13(6):339-51. PubMed ID: 17708420
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expanded CTG repeats trigger miRNA alterations in Drosophila that are conserved in myotonic dystrophy type 1 patients.
    Fernandez-Costa JM; Garcia-Lopez A; Zuñiga S; Fernandez-Pedrosa V; Felipo-Benavent A; Mata M; Jaka O; Aiastui A; Hernandez-Torres F; Aguado B; Perez-Alonso M; Vilchez JJ; Lopez de Munain A; Artero RD
    Hum Mol Genet; 2013 Feb; 22(4):704-16. PubMed ID: 23139243
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Myotonic dystrophy type 1 embryonic stem cells show decreased myogenic potential, increased CpG methylation at the DMPK locus and RNA mis-splicing.
    Franck S; Couvreu De Deckersberg E; Bubenik JL; Markouli C; Barbé L; Allemeersch J; Hilven P; Duqué G; Swanson MS; Gheldof A; Spits C; Sermon KD
    Biol Open; 2022 Jan; 11(1):. PubMed ID: 35019138
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fluid Biomarkers of Central Nervous System (CNS) Involvement in Myotonic Dystrophy Type 1 (DM1).
    Rossi S; Silvestri G
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768526
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanisms of skeletal muscle wasting in a mouse model for myotonic dystrophy type 1.
    Morriss GR; Rajapakshe K; Huang S; Coarfa C; Cooper TA
    Hum Mol Genet; 2018 Aug; 27(16):2789-2804. PubMed ID: 29771332
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Normal myogenesis and increased apoptosis in myotonic dystrophy type-1 muscle cells.
    Loro E; Rinaldi F; Malena A; Masiero E; Novelli G; Angelini C; Romeo V; Sandri M; Botta A; Vergani L
    Cell Death Differ; 2010 Aug; 17(8):1315-24. PubMed ID: 20431600
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Overview of the Complex Relationship between Epigenetics Markers, CTG Repeat Instability and Symptoms in Myotonic Dystrophy Type 1.
    de Pontual L; Tomé S
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408837
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mitochondrial dysfunction in myotonic dystrophy type 1.
    Gramegna LL; Giannoccaro MP; Manners DN; Testa C; Zanigni S; Evangelisti S; Bianchini C; Oppi F; Poda R; Avoni P; Lodi R; Liguori R; Tonon C
    Neuromuscul Disord; 2018 Feb; 28(2):144-149. PubMed ID: 29289451
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular mechanisms of muscle atrophy in myotonic dystrophies.
    Timchenko L
    Int J Biochem Cell Biol; 2013 Oct; 45(10):2280-7. PubMed ID: 23796888
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Altered expression and splicing of Ca(2+) metabolism genes in myotonic dystrophies DM1 and DM2.
    Vihola A; Sirito M; Bachinski LL; Raheem O; Screen M; Suominen T; Krahe R; Udd B
    Neuropathol Appl Neurobiol; 2013 Jun; 39(4):390-405. PubMed ID: 22758909
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correction of Glycogen Synthase Kinase 3β in Myotonic Dystrophy 1 Reduces the Mutant RNA and Improves Postnatal Survival of DMSXL Mice.
    Wang M; Weng WC; Stock L; Lindquist D; Martinez A; Gourdon G; Timchenko N; Snape M; Timchenko L
    Mol Cell Biol; 2019 Nov; 39(21):. PubMed ID: 31383751
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In silico discovery of substituted pyrido[2,3-d]pyrimidines and pentamidine-like compounds with biological activity in myotonic dystrophy models.
    González ÀL; Konieczny P; Llamusi B; Delgado-Pinar E; Borrell JI; Teixidó J; García-España E; Pérez-Alonso M; Estrada-Tejedor R; Artero R
    PLoS One; 2017; 12(6):e0178931. PubMed ID: 28582438
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fatigue in myotonic dystrophy type 1: a seven-year prospective study.
    Peric S; Bjelica B; Bozovic I; Pesovic J; Paunic T; Banovic M; Brkusanin M; Aleksic K; Basta I; Pavicevic DS; Stojanovic VR
    Acta Myol; 2019 Dec; 38(4):239-244. PubMed ID: 31970322
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prospective measurement of quality of life in myotonic dystrophy type 1.
    Peric S; Heatwole C; Durovic E; Kacar A; Nikolic A; Basta I; Marjanovic A; Stevic Z; Lavrnic D; Rakocevic Stojanovic V
    Acta Neurol Scand; 2017 Dec; 136(6):694-697. PubMed ID: 28660733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.